Hospital de Clínicas de Porto Alegre is a large teaching hospital located in Porto Alegre, Brazil. Affiliated with Federal University of Rio Grande do Sul, it was inaugurated in 1970, gradually becoming a reference for the state of Rio Grande do Sul and southern Brazil.

During the past decade, Hospital de Clinicas de Porto Alegre conducted 400 clinical trials. In the 10-year time frame, 400 clinical trials started and 107 clinical trials were completed, i.e. on average, 26.8% percent of trials that started reached the finish line to date. In the past 5 years, 184 clinical trials started and 66 clinical trials were completed. i.e. 35.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Clinicas de Porto Alegre" #1 sponsor was "Hospital de Clinicas de Porto Alegre" with 264 trials, followed by "Hoffmann-La Roche" with 57 trials sponsored, "Janssen Research & Development, LLC" with 19 trials sponsored, "Pfizer" with 19 trials sponsored and "Federal University of Rio Grande do Sul" with 19 trials sponsored. Other sponsors include 216 different institutions and companies that sponsored additional 133 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Clinicas de Porto Alegre" #1 collaborator was "Federal University of Rio Grande do Sul" with 29 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 25 trials as a collaborator, "Coordenação de Aperfeiçoamento de Pessoal de Nível Superior." with 17 trials as a collaborator, "Hospital de Clinicas de Porto Alegre" with 12 trials as a collaborator and "Ministry of Health, Brazil" with 12 trials as a collaborator. Other collaborators include 205 different institutions and companies that were collaborators in the rest 161 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Clinicas de Porto Alegre" are "Hypertension" (23 trials), "Heart Failure" (12 trials), "Fibromyalgia" (9 trials), "Breast Cancer" (8 trials) and "COVID-19" (8 trials). Many other conditions were trialed in "Hospital de Clinicas de Porto Alegre" in a lesser frequency.

Most popular intervention types in "Hospital de Clinicas de Porto Alegre" are "Drug" (334 trials), "Other" (127 trials), "Behavioral" (62 trials), "Device" (53 trials) and "Procedure" (31 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (125 trials), "Atezolizumab" (16 trials), "Cyclophosphamide" (8 trials), "Cisplatin" (7 trials) and "Control" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Clinicas de Porto Alegre" are 507 trials for "All" genders, 64 trials for "Female" genders and 22 trials for "Male" genders.

Currently, there are 174 active trials in "Hospital de Clinicas de Porto Alegre". 4 are not yet recruiting, 92 are recruiting, 75 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 242 completed trials in Hospital de Clinicas de Porto Alegre, 2 suspended trials, and 41 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Clinicas de Porto Alegre, 19 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 233 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 40 trials, and there were also 198 trials that are defined as “Not Applicable".